Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor-positive breast cancer Meeting Abstract
| Authors: | Krop, I.; Abramson, V.; Colleoni, M.; Traina, T.; Holmes, F.; Estevez, L.; Hart, L.; Awada, A.; Zamagni, C.; Morris, P.; Schwartzberg, L.; Chan, S.; Wheatley, D.; Gucalp, A.; Biganzoli, L.; Steinberg, J.; Gianni, L.; Trudeau, M.; Tudor, I. C.; Markova, D.; Barry, E.; Tarazi, J.; Stewart, R.; Winer, E.; Yardley, D. A. |
| Abstract Title: | Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor-positive breast cancer |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489400028 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-GS4-07 |
| Notes: | Meeting Abstract: GS4-07 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
